Last reviewed · How we verify
NCT04988438
Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19
trial in Gastrointestinal Motility Disorder in 120 participants. Status unknown.
30 September 2021
Quick facts
| Lead sponsor | University Hospital Dubrava |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 15 August 2021 |
| Primary completion | 30 September 2021 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across Croatia |
Conditions studied
- Gastrointestinal Motility Disorder — all drugs for Gastrointestinal Motility Disorder →
Sponsor
University Hospital Dubrava
Who can join
Adults 20 to 80, any sex, with Gastrointestinal Motility Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The patients who had COVID-19 infection, and after that reported for one of the signs of gastrointestinal disorder (esophageal and anorectal) will be underwent to esophageal and anorectal motor monitoring investigation (HRM manometry) on standard protocol.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Esophageal motility disorders after COVID-19 infection.
Babić Ž, Bezdrov L, Haber VE, Kardum D, et al · · 2025 · PMID 41353487 · DOI 10.1038/s41598-025-31067-1
Verify or expand the search:
- PubMed search for NCT04988438
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastrointestinal Motility Disorder
Currently open trials in the same condition.
- NCT06631001 — "The Effect of Abdominal Massage on Gastrointestinal Functions in Mechanically Ventilated Patients Receiving Enteral Nut · NA · recruiting
- NCT05989763 — Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis · NA · recruiting
- NCT06347367 — Short-term Effect of Exercise and Self-manual Approaches to Bloating - Distention · NA · active not recruiting
- NCT04208828 — IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy · recruiting
Other University Hospital Dubrava trials
Trials by the same sponsor.
- NCT07506304 — Biological Potentials in Arthroscopic All-inside Semitendinosus Anterior Cruciate Ligament Reconstruction · NA · not yet recruiting
- NCT07389434 — Feasibility, Safety, Cost-effectiveness, and Environmental Impact of Reprocessed Ablation Catheters in PVI · NA · recruiting
- NCT07339449 — Intraoperative Multimodal Monitoring as a Means in Reducing the Duration of Mechanical Ventilation in High-Risk Patients · NA · recruiting
- NCT06969586 — The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy · enrolling by invitation
- NCT06960629 — The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK) · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04988438 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Dubrava
- Last refreshed: 30 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04988438.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing